Valuation: Vector Science and Therapeutics Corp.

Market Cap 24Cr 22Cr 20Cr 18Cr 34Cr 2.3TCr 34Cr 240.93Cr 96Cr 1.21TCr 91Cr 89Cr 3.83TCr P/E 2024 *
-
P/E 2025 -0.29x
Enterprise Value 24Cr 22Cr 20Cr 18Cr 34Cr 2.28TCr 34Cr 238.07Cr 95Cr 1.19TCr 90Cr 88Cr 3.78TCr EV / Sales 2024 *
-
EV / Sales 2025 -
Free-Float
75.71%
Yield 2024 *
-
Yield 2025 -
22/10 Vector Science and Therapeutics Corp. Introduces Peptide-Matrix Microneedle Technology for Targeted Transdermal Delivery of Peptides CI
19/10 Vector Science and Therapeutics Corp. Announces Appointment of Angus Jackson as Managing Director of Corporate Development CI
14/10 Vector Science & Therapeutics Corp. Announces the Appointment of Russell Starr as President of the Company, Effective October 5, 2026 CI
13/10 Vector Science and Therapeutics Corp. Announces Collaboration and Safe Investment in Whoopi Wellness, Inc CI
13/10 Whoopi Wellness, Inc. announced that it has received funding from Vector Science and Therapeutics Corp. CI
07/10 Scoreboard, Inc. announced that it has received funding from Vector Science and Therapeutics Corp. CI
07/10 Vector Science And Therapeutics Corp. Announces Collaboration With SAFE Investment In Scoreboard, Inc CI
24/08 Vector Science Starts Manufacturing Pharma-Grade Peptides MT
24/08 Vector Science & Therapeutics Increases Peptide Manufacturing Capacity At Lyogenesis Facility CI
24/08 Vector Science & Therapeutics Begins Peptide Production As First Suite At LyoGenesis Manufacturing Comes Online CI
20/08 Vector Science and Therapeutics Corp Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides CI
17/08 Vector Science and Therapeutics Signs Amended 10-Year Manufacturing and Testing Agreement MT
17/08 Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement With LyoGenesis Holdings LLC CI
1 day+7.89%
1 week+1.23%
Current month-14.14%
1 month-15.03%
3 months-1.80%
6 months+3,180.00%
Current year+3,180.00%
1 week 1.52
Extreme 1.52
1.65
1 month 1.5
Extreme 1.5
2.03
Current year 0.35
Extreme 0.35
2.65
1 year 0.35
Extreme 0.35
2.65
3 years 0.04
Extreme 0.035
2.65
5 years 0.03
Extreme 0.03
2.65
10 years 0.03
Extreme 0.03
2.65
Date Insider Type Main position Quantity % Market Cap. Importance
25/09/26 Option

Chief Financial Officer

1,50,000 0.1548%
28/08/26 Sell

Director

-1,25,000 0.1302%
13/07/26 Buy

Director

2,000 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+7.89%+1.23%+3,180.00%+5,366.67% 18Cr
+0.24%+1.78%+32.49%+109.00% 13TCr
+0.19%+0.97%+30.78%+84.27% 2.25TCr
-0.24%+2.19%+22.27%+59.39% 1.69TCr
-1.76%-4.87%+7.89%+147.48% 1.49TCr
-0.22%+1.22%+13.17%+29.32% 1.45TCr
0.00%+3.99%-11.74%+14.37% 1.39TCr
-3.54%-4.48%-18.25%+53.61% 1.27TCr
-1.40%-2.04%+18.05%+33.79% 1.22TCr
-0.33%-5.44%+53.26%+71.67% 1.19TCr
Average +0.09%-0.15%+332.79%+596.96% 2.49TCr
Weighted average by Cap. -0.25%+1.13%+26.59%+91.39%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Projected Income Statement - Annual - Vector Science and Therapeutics Corp.
Logo Vector Science and Therapeutics Corp.
Vector Science and Therapeutics Corp. is a Canada-based company. The Company develops novel biomechanical devices and active localized drug delivery platforms to equip clinicians with site-directed interventions. The Company's product platforms and applications include Laparoscopic Atomizing Solution System (LASS) and Biomechanical Transdermal Device (BTP). The LASS Platform is an atomizing solution system designed to deliver therapeutics/anesthetics in a manner that infiltrates tissue to have a specific therapeutic effect. VectorMist is a catheter-based system designed for targeted delivery of atomized therapeutics directly into the surgical field during laparoscopic procedures. Vector BTP is an electrical biomechanical platform that functions as both a standalone therapeutic intervention and a drug delivery platform competing directly with sustained acoustic medicine devices and pulsed electromagnetic field devices in the regenerative and sports medicine segments.
Employees
-
Date Price Change Volume
27/26/27 CA$1.640 +7.89% 1,57,781
26/26/26 CA$1.520 -1.94% 3,151
23/26/23 CA$1.550 -3.13% 13,232
22/26/22 CA$1.600 +0.63% 85,284
21/26/21 CA$1.590 -1.85% 1,27,010
  1. Stock Market
  2. Stocks
  3. PAIN Stock